Trial
NCT04827576
Study of Magrolimab in Patients With Solid Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Solid Tumor
Intervention
Magrolimab
Why stopped
Sponsor decision to terminate study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-08